The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer
These results suggest that T lymphocyte subsets may be a predictive biomarker for treatment response in patients with breast cancer undergoing neoadjuvant chemotherapy. Further studies are needed to confirm these findings and to identify the optimal T lymphocyte subset for predicting treatment response.
Authors
- Tarkan Yetişyiğit (ORCID: https://orcid.org/0000-0002-4622-4742)
- S. Seber (ORCID: https://orcid.org/0000-0001-9081-2405)
- Yakup İriağaç (ORCID: https://orcid.org/0000-0001-7411-1705)
- Meltem Öznur (ORCID: https://orcid.org/0000-0002-6396-3168)
- Kubilay Karaboyun (ORCID: https://orcid.org/0000-0002-1783-8075)
- Eyyüp Çavdar (ORCID: https://orcid.org/0000-0001-5885-3047)
- Burhan Turgut (ORCID: https://orcid.org/0000-0001-5729-0043)
Institutions
- Balıkesir University (TR)
- Tekirdağ Namık Kemal University (TR)
- Salmaniya Medical Complex (BH)
- Istinye University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Medicine
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1097/md.0000000000044743
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00